DIG revisited: Digoxin scrutinized anew for chronic heart failureTheHeart.OrgBelgrade, Serbia – Subgroup data from a 15-year-old trial, publicly released for the first time, suggests an old drug has potential for broader use in chronic heart failure ev…
Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with … – MarketWatch (press release)
Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with …MarketWatch (press release)This dose-ranging study evaluated 105 patients 12 to 17 years of age with moderate, persistent asthma on medium dose inhaled corticosteroids (ICS)…
Organ Failure in Sepsis Not Cut with Two Drugs – MedPage Today
Organ Failure in Sepsis Not Cut with Two DrugsMedPage TodayIn this study, empirical treatment of severe sepsis with two antibiotics instead of one did not reduce organ failure. Note that the combination also had no significant effect on mortality. SAN …
Danger in standard lung disease treatment – CBS42
Danger in standard lung disease treatmentCBS42The standard care to treat IPF consists of a combination of three drugs: Prednisone, Azathioprine, and N-Acetylcysteine. The study was conducted by the IPF Clinical Research Network and funded by the Nation…
New European guidelines set to benefit heart failure patients in the UK – PharmiWeb.com (press release)
New European guidelines set to benefit heart failure patients in the UKPharmiWeb.com (press release)[Walton Oaks], 21st May, 2012 ‚Äì The European Society for Cardiology (ESC) has announced an update to their guidelines for the management of chroni…
FDA staff shoots down Pfizer rare disease drug
Drug reviewers on Tuesday recommended rejecting a Pfizer Inc drug because the data did not prove it worked well in treating a rare neurodegenerative disease. The U.S. Food and Drug Administration staff …
Statins Protect From Cancer In Heart Transplant Patients
Researchers presented a study at the Heart Failure Association of the European Society of Cardiology's 2012 Heart Failure Congress in Belgrade, Serbia, which revealed that statins are linked to preventing cancer and reduce all-cause mortality risk …
Novel Diuretic Promising for Heart Failure – MedPage Today
Novel Diuretic Promising for Heart FailureMedPage TodayA novel compound, cross-linked polyelectrolyte (CLP), that acts like a diuretic but without relying on the kidneys may improve outcomes for heart failure patients with chronic kidney disease. Note …
Study finds FDA-approved drug makes established cancer vaccine work better – Westmoreland County Times
Study finds FDA-approved drug makes established cancer vaccine work betterWestmoreland County TimesA team from the Perelman School of Medicine and the Abramson Family Cancer Research Institute at the University of Pennsylvania found that the FDA-approv…
Sorbent Therapeutics' CLP1001 Improves Heart Failure Symptoms In Phase 2 … – MarketWatch (press release)
Sorbent Therapeutics' CLP1001 Improves Heart Failure Symptoms In Phase 2 …MarketWatch (press release)In the study of 111 heart failure patients with chronic kidney disease, CLP1001 demonstrated improvement in heart failure symptoms as compared to…